The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens.
Citation: Journal of Gastrointestinal Oncology. 12(Suppl 1):S129-S130, 2021 Apr.PMID: 33970156Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2021ISSN:- 2078-6891
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 33970156 | Available | 33970156 |
English